Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity

Ischemic stroke (IS) constitutes the leading cause of global morbidity and mortality. Neuroprotectants are essential to ameliorate the clinical prognosis, but their therapeutic outcomes are tremendously compromised by insufficient delivery to the ischemic lesion and intricate pathogenesis associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zhuang, Meng, Shiyu, Song, Zhiling, Yang, Xiaoxue, Li, Xinzhi, Guo, Hui, Du, Meirong, Chen, Jun, Zhu, Yi Zhun, Wang, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238753/
https://www.ncbi.nlm.nih.gov/pubmed/37273794
http://dx.doi.org/10.1016/j.mtbio.2023.100674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238753/
https://www.ncbi.nlm.nih.gov/pubmed/37273794
http://dx.doi.org/10.1016/j.mtbio.2023.100674

Ejemplares similares